Latanoprostene bunod clinical trials
Also written BOL-303259-X and Vyzulta.
How each study uses latanoprostene bunod is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- 2 Nov 2017 · VYZULTA · NDA 207795 (FDA, Drugs@FDA)
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
9 studies that test it; most in 2013 (4)
| Year | Studies |
|---|---|
| 2010 | 1 |
| 2012 | 1 |
| 2013 | 4 |
| 2018 | 1 |
| 2019 | 1 |
| 2022 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 7 · Other 2
Bausch & Lomb Incorporated (7) · University of California, San Diego (1) · Icahn School of Medicine at Mount Sinai (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses latanoprostene bunod is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 9
- A Study to Evaluate the Effect of Latanoprostene Bunod Ophthalmic Solution 0.024% on Episcleral Venous Pressure and Outflow Facility in Participants With Ocular HypertensionWithdrawnPhase 4Bausch & Lomb IncorporatedNCT04140279Written as Latanoprostene BunodHow we know
- Study Comparing the Effects of Latanoprostene Bunod and Timolol on Retinal Blood Vessel Density and Visual AcuityCompletedNot applicableUniversity of California, San DiegoNCT03931317Written as Latanoprostene bunod 0.024% QDHow we know
- Nailfold Capillary Blood Flow With Latanoprost BunodCompletedPhase 4Icahn School of Medicine at Mount SinaiNCT03949244Written as Latanoprost bunod 0.024%How we know
- Comparing the Safety and Efficacy of BOL-303259-X Ophthalmic Solution With Timolol Maleate Ophthalmic Solution in Subjects With Open-Angle Glaucoma or Ocular HypertensionCompletedPhase 3Bausch & Lomb IncorporatedNCT01749930Written as BOL-303259-XHow we know
- Comparing Safety and Efficacy of BOL-303259-X With Timolol Maleate in Subjects With Open-Angle Glaucoma or Ocular HypertensionCompletedPhase 3Bausch & Lomb IncorporatedNCT01749904Written as BOL-303259-XHow we know
- BOL-303259-X With Timolol 0.5% in Subjects With Open-Angle Glaucoma or Ocular HypertensionCompletedPhase 2Bausch & Lomb IncorporatedNCT01707381Written as BOL-303259-XHow we know
- Long-Term Safety of Latanoprostene Bunod Ophthalmic Solution 0.024% in Japanese Subjects With OAG or OHTCompletedPhase 3Bausch & Lomb IncorporatedNCT01895972Written as Latanoprostene bunodHow we know
- Study Comparing the Safety and Efficacy of BOL-303259-X to Latanoprost in Subjects With Glaucoma or Ocular HypertensionCompletedPhase 2Bausch & Lomb IncorporatedNCT01223378Written as BOL-303259-XHow we know
- Efficacy of Latanoprostene Bunod in Lowering Intraocular Pressure in Japanese Healthy Male VolunteersCompletedPhase 1Bausch & Lomb IncorporatedNCT01895985Written as Latanoprostene bunodHow we know
Codes
What other systems call latanoprostene bunod · ClinicalTrials.gg INT005954
- UNII (FDA) I6393O0922LATANOPROSTENE BUNODConfirmed FDA, Wikidata
- RxNorm 1988390One source FDA
- Wikidata Q27280492latanoprostene bunodConfirmed FDA, Wikidata
- NCI Thesaurus C170095Latanoprostene BunodOne source FDA
- DrugBank DB11660One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | I6393O0922 | LATANOPROSTENE BUNOD | Confirmed FDA, Wikidata |
| RxNorm | 1988390 | — | One source FDA |
| Wikidata | Q27280492 | latanoprostene bunod | Confirmed FDA, Wikidata |
| NCI Thesaurus | C170095 | Latanoprostene Bunod | One source FDA |
| DrugBank | DB11660 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.